Cargando…
Development of an Albumin-Based PSMA Probe With Prolonged Half-Life
Prostate-specific membrane antigen (PSMA) is an attractive target for the diagnosis and therapy of prostate cancer as it is specifically overexpressed in prostate cancer cells. Improving the circulation of radioligands in the blood is considered as an effective strategy that can improve tumor burden...
Autores principales: | Liu, Teli, Liu, Chen, Ren, Yanan, Guo, Xiaoyi, Jiang, Jinquan, Xie, Qing, Xia, Lei, Wang, Feng, Zhu, Hua, Yang, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773938/ https://www.ncbi.nlm.nih.gov/pubmed/33392253 http://dx.doi.org/10.3389/fmolb.2020.585024 |
Ejemplares similares
-
An Albumin-Binding PSMA Ligand with Higher Tumor Accumulation for PET Imaging of Prostate Cancer
por: Ren, Ya’nan, et al.
Publicado: (2022) -
Albumin Alters the Conformational Ensemble of Amyloid-β by Promiscuous Interactions: Implications for Amyloid Inhibition
por: Xie, Huisi, et al.
Publicado: (2021) -
In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19
por: Teli, Divya M., et al.
Publicado: (2021) -
CMTM6 as a candidate risk gene for cervical cancer: Comprehensive bioinformatics study
por: Huang, Xiaoting, et al.
Publicado: (2022) -
A Type I Collagen-Targeted MR Imaging Probe for Staging Fibrosis in Crohn’s Disease
por: Li, Zhoulei, et al.
Publicado: (2021)